Opinion-Based Recommendations: Beware the Tyranny of Experts

Overview

Journal Open Forum Infect Dis

Specialty Infectious Diseases

Date 2021 Nov 22

PMID 34805432

Citations 1

Authors

Brad Spellberg

Andrew F Shorr

Affiliations

Soon will be listed here.

Citing Articles

Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV.

Davar K, Clark D, Centor R, Dominguez F, Ghanem B, Lee R Open Forum Infect Dis. 2023; 10(1):ofac706.

PMID: 36694838 PMC: 9853939. DOI: 10.1093/ofid/ofac706.

References

Fang G, Brennen C, Wagener M, Swanson D, Hilf M, Zadecky L . Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study. Antimicrob Agents Chemother. 1991; 35(9):1849-55. PMC: 245279. DOI: 10.1128/AAC.35.9.1849. View

Fass R, Plouffe J, Russell J . Intravenous/oral ciprofloxacin versus ceftazidime in the treatment of serious infections. Am J Med. 1989; 87(5A):164S-168S. DOI: 10.1016/0002-9343(89)90050-8. View

Drekonja D, Trautner B, Amundson C, Kuskowski M, Johnson J . Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial. JAMA. 2021; 326(4):324-331. PMC: 8317010. DOI: 10.1001/jama.2021.9899. View

Park T, Choi J, Song T, Do J, Choi S, Oh H . Early oral antibiotic switch compared with conventional intravenous antibiotic therapy for acute cholangitis with bacteremia. Dig Dis Sci. 2014; 59(11):2790-6. DOI: 10.1007/s10620-014-3233-0. View

Sawyer R, Claridge J, Nathens A, Rotstein O, Duane T, Evans H . Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015; 372(21):1996-2005. PMC: 4469182. DOI: 10.1056/NEJMoa1411162. View

Solomkin J, Reinhart H, Dellinger E, Bohnen J, Rotstein O, Vogel S . Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. Ann Surg. 1996; 223(3):303-15. PMC: 1235120. DOI: 10.1097/00000658-199603000-00012. View

Klausner H, Brown P, Peterson J, Kaul S, Khashab M, Fisher A . A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. Curr Med Res Opin. 2007; 23(11):2637-45. DOI: 10.1185/030079907x233340. View

Sandberg T, Skoog G, Hermansson A, Kahlmeter G, Kuylenstierna N, Lannergard A . Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012; 380(9840):484-90. DOI: 10.1016/S0140-6736(12)60608-4. View

de Gier R, Karperien A, Bouter K, Zwinkels M, Verhoef J, Knol W . A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections. Int J Antimicrob Agents. 1995; 6(1):27-30. DOI: 10.1016/0924-8579(95)00011-v. View

10.

Chastre J, Wolff M, Fagon J, Chevret S, Thomas F, Wermert D . Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003; 290(19):2588-98. DOI: 10.1001/jama.290.19.2588. View

11.

Heil E, Bork J, Abbo L, Barlam T, Cosgrove S, Davis A . Optimizing the Management of Uncomplicated Gram-Negative Bloodstream Infections: Consensus Guidance Using a Modified Delphi Process. Open Forum Infect Dis. 2021; 8(10):ofab434. PMC: 8561258. DOI: 10.1093/ofid/ofab434. View

12.

Peterson J, Kaul S, Khashab M, Fisher A, Kahn J . A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology. 2008; 71(1):17-22. DOI: 10.1016/j.urology.2007.09.002. View

13.

Wacha H, Warren B, Bassaris H, Nikolaidis P . Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections. Surg Infect (Larchmt). 2006; 7(4):341-54. DOI: 10.1089/sur.2006.7.341. View

14.

Dinh A, Davido B, Etienne M, Bouchand F, Raynaud-Lambinet A, Aslangul-Castier E . Is 5 days of oral fluoroquinolone enough for acute uncomplicated pyelonephritis? The DTP randomized trial. Eur J Clin Microbiol Infect Dis. 2017; 36(8):1443-1448. DOI: 10.1007/s10096-017-2951-6. View

15.

Talan D, Stamm W, Hooton T, Moran G, Burke T, Iravani A . Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA. 2000; 283(12):1583-90. DOI: 10.1001/jama.283.12.1583. View

16.

Amodio-Groton M, Madu A, Madu C, Briceland L, Seligman M, McMaster P . Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis. Ann Pharmacother. 1996; 30(6):596-602. DOI: 10.1177/106002809603000605. View

17.

Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R . Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial. Clin Infect Dis. 2018; 69(7):1091-1098. DOI: 10.1093/cid/ciy1054. View

18.

Guallar E, Laine C . Controversy over clinical guidelines: listen to the evidence, not the noise. Ann Intern Med. 2014; 160(5):361-2. DOI: 10.7326/M14-0112. View

19.

JERNELIUS H, ZBORNIK J, Bauer C . One or three weeks' treatment of acute pyelonephritis? A double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam. Acta Med Scand. 1988; 223(5):469-77. DOI: 10.1111/j.0954-6820.1988.tb15899.x. View

20.

Spellberg B, Wright W, Shaneyfelt T, Centor R . The Future of Medical Guidelines: Standardizing Clinical Care With the Humility of Uncertainty. Ann Intern Med. 2021; 174(12):1740-1742. DOI: 10.7326/M21-3034. View